Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 3 | 2022 | 10 | 1.640 |
Why?
|
| Hypoglycemic Agents | 2 | 2019 | 106 | 1.230 |
Why?
|
| Indoles | 4 | 2021 | 98 | 1.120 |
Why?
|
| Drug Design | 3 | 2021 | 62 | 0.970 |
Why?
|
| Protective Agents | 2 | 2021 | 17 | 0.850 |
Why?
|
| PPAR gamma | 2 | 2021 | 29 | 0.840 |
Why?
|
| Molecular Probes | 1 | 2021 | 13 | 0.750 |
Why?
|
| Chelating Agents | 1 | 2021 | 22 | 0.750 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 37 | 0.740 |
Why?
|
| Technetium | 1 | 2021 | 43 | 0.730 |
Why?
|
| Pancreas | 1 | 2021 | 59 | 0.730 |
Why?
|
| Zinc | 1 | 2021 | 63 | 0.720 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2021 | 36 | 0.700 |
Why?
|
| Benzamides | 1 | 2019 | 33 | 0.660 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 213 | 0.660 |
Why?
|
| Endoribonucleases | 3 | 2025 | 10 | 0.630 |
Why?
|
| Molecular Structure | 3 | 2021 | 240 | 0.370 |
Why?
|
| Structure-Activity Relationship | 3 | 2020 | 204 | 0.360 |
Why?
|
| Nitro Compounds | 2 | 2020 | 10 | 0.350 |
Why?
|
| Apoptosis | 4 | 2022 | 740 | 0.350 |
Why?
|
| Benzopyrans | 2 | 2020 | 17 | 0.350 |
Why?
|
| Insulin | 2 | 2021 | 315 | 0.330 |
Why?
|
| Insulin Resistance | 2 | 2025 | 172 | 0.260 |
Why?
|
| Thermogenesis | 1 | 2025 | 12 | 0.240 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 660 | 0.240 |
Why?
|
| Mice | 6 | 2025 | 4478 | 0.220 |
Why?
|
| Adipose Tissue | 1 | 2025 | 180 | 0.210 |
Why?
|
| Macrophages | 1 | 2025 | 280 | 0.200 |
Why?
|
| Unfolded Protein Response | 1 | 2022 | 24 | 0.200 |
Why?
|
| Triazoles | 1 | 2022 | 15 | 0.200 |
Why?
|
| Obesity | 2 | 2025 | 655 | 0.190 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 16 | 0.190 |
Why?
|
| Cell Survival | 2 | 2020 | 396 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 590 | 0.190 |
Why?
|
| Colchicine | 1 | 2020 | 15 | 0.180 |
Why?
|
| Tubulin | 1 | 2020 | 30 | 0.180 |
Why?
|
| Tubulin Modulators | 1 | 2020 | 16 | 0.180 |
Why?
|
| Coronary Vessels | 1 | 2022 | 151 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 96 | 0.170 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 247 | 0.170 |
Why?
|
| Animals | 6 | 2025 | 10093 | 0.170 |
Why?
|
| Solubility | 1 | 2019 | 73 | 0.170 |
Why?
|
| Amino Acids | 1 | 2019 | 82 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 116 | 0.160 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 342 | 0.160 |
Why?
|
| Models, Molecular | 1 | 2019 | 445 | 0.150 |
Why?
|
| Humans | 5 | 2022 | 27171 | 0.110 |
Why?
|
| Mice, Obese | 2 | 2025 | 21 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 102 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1498 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2020 | 775 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 1271 | 0.070 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 134 | 0.060 |
Why?
|
| Streptavidin | 1 | 2022 | 11 | 0.050 |
Why?
|
| Fibronectins | 1 | 2022 | 28 | 0.050 |
Why?
|
| Glucaric Acid | 1 | 2022 | 10 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2022 | 29 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 26 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 9 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2021 | 28 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2022 | 132 | 0.050 |
Why?
|
| Necrosis | 1 | 2022 | 82 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 75 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 59 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 140 | 0.050 |
Why?
|
| Ligands | 1 | 2021 | 170 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 98 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2021 | 176 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 113 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 47 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 30 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 60 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 66 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2020 | 218 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2021 | 978 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 626 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 325 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 820 | 0.040 |
Why?
|
| Male | 1 | 2025 | 13041 | 0.020 |
Why?
|